Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.
Prapela's investors include Baylor College of Medicine, National Institutes of Health, Johnson & Johnson, Massachusetts Life Sciences Center, U.S. Small Business Administration.
Prapela is headquartered in Biddeford, United States.
Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.
Prapela is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prapela — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/prapela. Accessed July 19, 2026.
VCBacked. (2023). Prapela — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/prapela
{{cite web |title=Prapela — Funding & Investors |url=https://www.vcbacked.co/company/prapela |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated